Zobrazeno 1 - 10
of 428
pro vyhledávání: '"Flook N"'
Autor:
VAN ZANTEN, S. V.1 (AUTHOR), FLOOK, N.2 (AUTHOR), TALLEY, N. J.3,4 (AUTHOR), VAKIL, N.5 (AUTHOR), LAURITSEN, K.6 (AUTHOR), BOLLING‐STERNEVALD, E.7 (AUTHOR), PERSSON, T.7 (AUTHOR), BJÖRCK, E.6 (AUTHOR), SVEDBERG, L.‐E.7 (AUTHOR)
Publikováno v:
Alimentary Pharmacology & Therapeutics. Sep2007, Vol. 26 Issue 5, p665-672. 8p. 2 Diagrams, 2 Charts, 1 Graph.
Autor:
Flook, N W, Wiklund, I
Publikováno v:
International Journal of Clinical Practice
Aim To review, from a primary care physician (PCP) perspective, the use of patient-reported outcome (PRO) instruments for assessment of gastro-oesophageal reflux disease (GERD) symptoms, their impact on health-related quality of life (HRQL) and the e
Autor:
Veldhuyzen van Zanten, S, Wahlqvist, P, Talley, N J, Halling, K, Vakil, N, Lauritsen, K, Flook, N, Persson, T, Bolling-Sternevald, E
Publikováno v:
Veldhuyzen van Zanten, S, Wahlqvist, P, Talley, N J, Halling, K, Vakil, N, Lauritsen, K, Flook, N, Persson, T, Bolling-Sternevald, E & on behalf of the STARS II Investigators 2011, ' Randomised clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole-results from the STARS II study ', Alimentary Pharmacology and Therapeutics, vol. 34, no. 7, pp. 714-723 . https://doi.org/10.1111/j.1365-2036.2011.04789.x
Aliment Pharmacol Ther 2011; 34: 714-723 SUMMARY: Background Patients with dyspepsia often experience troublesome symptoms. Aim To assess the burden of uninvestigated dyspepsia (symptoms, health-related quality of life [HRQL] and work productivity) b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3062::e66a55f5e2cc5d50b0136ceaa279b096
https://portal.findresearcher.sdu.dk/da/publications/5333e874-d33c-4575-827f-445fcd3a9baa
https://portal.findresearcher.sdu.dk/da/publications/5333e874-d33c-4575-827f-445fcd3a9baa
Autor:
VAKIL N, TALLEY N, VAN ZANTEN SV, FLOOK N, PERSSON T, BJÖRCK E, LIND T, BOLLING STERNEVALD E, STARS I. STUDY GROUP: BAI JC, SEGAL E, DI RISIO C, PEDRANA R, RAINOLDI J, MILUTIN M, PALAZZO F, MACKEN E, BAETENS P, D'HAENS G, CABOOTER M, MARTINET JP, DELWAIDE J, PIESSEVAUX H, BUSET M, JANSSENS J, VERGAUWE P, POLLET S, QUILICI F, RODRIGUEZ TN, DA SILVA EP, NADER F, LUIZ JORGE J, ACHILLES P, CORRÊA BL, GUEDES J, CLARK D, PLOURDE, DESAI M, MORGAN EP, GRAY J, COHEN A, REDDY S, JOBIN G, SADOWSKI D, KELLY A, MORGAN D, ING G, LIANG W, TYTUS R, TEITELBAUM I, LASKO B, KASSNER R, CARLSON B, O'KEEFE D, SOMANI R, GREENSPOON A, FAIERS A, BANKS M, JARDINE F, WOODLAND R, LUCES K, COX R, ROLFE A, FAY D, AKHRAS D, MAZZA G, KIILERICH S, BYTZER P, HENDEL L, ERIKSEN J, THORDAL C, VADSTRUP S, FLY G, GOLDFAIN D, COULANJON G, LEOTHAUD G, DELETTE O, MATHONIERE O, ZRIHEN D, LEMAITRE JP, PEIGNOT JF, BARBERIS A, TORDJMAN G, GOMPEL M, GRANDGUILLAUME J, MARCIANO P, LE TEXIER A, BOYE A, TONDUT A, SCHEER J, SCHMIDT W, KÖLLING W, REGLING S, ALASMAR D, BECKER TESCH A, LEHMANN R, SCHIRRMEISTER G, SPEETZEN G, STAHL HD, ROITENBERG A, KITIS GE, KARAMANOLIS D, TRIANTAFILLOU G, TZIVRAS M, AVGERINOS A, BJÖRNSSON ORVAR K, KRISTJÁNSDÓTTIR, BIRGISSON, VALDIMARSSON, BJÖRNSSON S, SPISNI R, SCARPULLA G, MINOLI G, DELLA BIANCA G, BIANCO MA, PISTOIA MA, VAIRA D, LONGHINI A, CESTARI R, JOMAAS H, JOHANSEN Y, LIER J, LØLAND O, SKJEGSTAD E, JØRUM IM, FONNELØP H, WANGESTAD M, TOMASSEN ST, NORDSTRAND A, HERTZENBERG AB, SAEBØ L, MANSILLA TINOCO R, NORHEIM PD, SOLNØR L, LUNDBY B, TOMALA T, SANAKER H, FAUSKE J, OSHAUG M, LINDSTRØM M, RUDNEVA E, HANSEN AN, SKAG A, WERNER EL, AHLQVIST JO, BØ PE, KJØRLAUG K, EIKELAND T, HATLEBREKKE T, OLSEN K, TUDOR N, DOBRU D, REDIS R, COMAN F, BALADAS H, FOCK KW, HO LK, LIM CC, GROBLER S, ALLY R, ABOO N, VAN RENSBURG C, MOHAME H, SCHNEIDER H, PRINS M, MOOLA S, BEKKER J, ABAD A, MEARIN MANRIQUE F, DOMINGUEZ E, HERRERIAS GUTIÉRREZ JM, DIAZ RUBIO M, WEDÉN M, EDIN R, UNG KA, TOTH E, JOHNSSON F, STUBBERÖD A, TOUR R, FALK A, HULTBER C, LARNEFELDT H, LÖNNEBORG L, ERICSSON M, KNUTSSON AC, FRÖBERG L, LARSSON A, TRACZ S, HOLLENBERG S, WIDE S, POLHEM B, PAULSSON L, GRIMFORS S, ROOS H, SKALENU JO, WEBER KB, STANGHELLINI, VINCENZO
BACKGROUND & AIMS: Current guidelines recommend empirical, noninvasive approaches to manage dyspeptic patients without alarm symptoms, but concerns about missed lesions persist; the cost savings afforded by noninvasive approaches must be weighed agai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b33162d6e6bf239aff2c5e76d848677a
http://hdl.handle.net/11379/38640
http://hdl.handle.net/11379/38640
Autor:
van Zanten, S V, Flook, N, Talley, N J, Vakil, N, Lauritsen, K, Bolling-Sternevald, E, Persson, T, Björck, E, Svedberg, L-E, II Study Group, STARS
Publikováno v:
van Zanten, S V, Flook, N, Talley, N J, Vakil, N, Lauritsen, K, Bolling-Sternevald, E, Persson, T, Björck, E, Svedberg, L-E & II Study Group, STARS 2007, ' One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks' treatment with esomeprazole : a randomized, placebo-controlled study ', Alimentary Pharmacology and Therapeutics, vol. 26, no. 5, pp. 665-672 .
Udgivelsesdato: Sep-1 BACKGROUND: While empiric acid-suppressive therapy for uninvestigated dyspepsia patients with symptoms of epigastric pain or burning is standard practice, it is unknown whether an early response to therapy predicts outcome. AIM:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3062::18ae4dfaf24b863aef245a987e004ce3
https://portal.findresearcher.sdu.dk/da/publications/da3bb810-ca55-11dc-8674-000ea68e967b
https://portal.findresearcher.sdu.dk/da/publications/da3bb810-ca55-11dc-8674-000ea68e967b
Autor:
Nimish, Vakil, Talley, N, van Zanten SV, Flook, N, Persson, T, Björck, E, Lind, T, Bolling Sternevald, E, Spisni, Roberto, Study Group, STARS I.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3728::eb1e2ece053153bdb1bdddc8f05e6d12
http://hdl.handle.net/11568/130112
http://hdl.handle.net/11568/130112
Autor:
Talley, N. J., Vakil, N., Lauritsens, K., Van Zanten, S. V., Flook, N., Bolling Sternevald, E., Persson, T., Bjorck, E., Lind, T., Spisni, Roberto, Study Group, Stars I.
Early identification of true responders to acid suppression in functional dyspepsia patients with symptoms of epigastric pain or burning may enable clinicians to optimally tailor treatment.To evaluate whether a 1-w acid suppression trial is useful fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::161f648f6d5d64c785dd188786ec41e2
http://hdl.handle.net/11568/117883
http://hdl.handle.net/11568/117883
Autor:
Wahlqvist, P., Persson, T., Brun, J., Flook, N., Lauritsen, K., Vakil, N., Veldhuyzen van Zanten, S., Halling, K., Talley, N., Spisni, Roberto, Study Group, STARS I.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3728::d8cdcaf32158f42a372d71d630708a73
http://hdl.handle.net/11568/107867
http://hdl.handle.net/11568/107867
Autor:
Veldhuyzen van Zanten, S., Wahlqvist, P., Talley, N. J., Halling, K., Vakil, N., Lauritsen, K., Flook, N., Persson, T., Bolling‐Sternevald, E.
Publikováno v:
Alimentary Pharmacology & Therapeutics; Oct2011, Vol. 34 Issue 7, p714-723, 10p, 5 Charts